Charting a Path for Compliance in Life Sciences
Event | 02.25.25, 5:00 PM EST - 8:00 PM EST
Address
Crowell & Morning’s Jason Johnson, a member of the firm's Health Care and Privacy and Cybersecurity groups, will be speaking at Charting a Path for Compliance in Life Sciences, on Tuesday, February 25, 2025, at Crowell's New York office. His presentation, "Supporting Regulatory Compliance Laws," will take place at 5:40 p.m. EST.
Join us for an interactive and educational event tailored for biotech leaders seeking to ensure security compliance while leveraging the power of Amazon Web Services (AWS). This session will dive into the critical elements of designing secure, scalable, and compliant systems for biotech operations, from research and development to clinical trials and beyond.
What We'll Cover:
- Key compliance frameworks for biotech (HIPAA, GDPR, GxP, and more) and how to address them.
- Best practices for securing sensitive data like personal identifiable information (PII), genomic information, and intellectual property.
- Strategies for implementing AWS services, such as Amazon GuardDuty, AWS Identity and Access Management (IAM), and AWS Config, to achieve compliance.
- Real-world use cases of biotech companies overcoming security challenges with AWS solutions.
Steps to ensure audit readiness and proactive risk management in regulated environments
For more information, please visit these areas: Health Care, Life Sciences, Health Care
Participants
Insights
Event | 02.20.25
Has the Buss Stopped? Recoupment Today
Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.
Event | 02.18.25 - 02.20.25
Event | 12.05.24
Event | 12.05.24
